Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

July 31, 2016

Conditions
Facial Angiofibroma
Interventions
DRUG

Rapamune

Small amount of 0.1% rapamune ointment applied topically to affected facial areas twice daily for the first two weeks, then once daily.

Trial Locations (1)

38103

LeBonheur Children's Hospital, Memphis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

collaborator

University of Tennessee

OTHER

lead

Le Bonheur Children's Hospital

OTHER